These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9120665)

  • 1. Concomitant diseases in elderly hypertensives: the position of nicardipine.
    Zannad F
    J Hypertens Suppl; 1996 Oct; 14(3):S37-40. PubMed ID: 9120665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium channel antagonists. Part III: Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications.
    Opie LH
    Cardiovasc Drugs Ther; 1988 Mar; 1(6):625-56. PubMed ID: 3154329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicardipine in heart failure: distinguishing its acute beneficial from its chronic effects.
    Sy J; Vitarelli A; Gheorghiade M
    Minerva Cardioangiol; 1993 Nov; 41(11):535-41. PubMed ID: 8127455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clevidipine: a review of its use in the management of acute hypertension.
    Deeks ED; Keating GM; Keam SJ
    Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential advantages of a modern antihypertensive therapy in the elderly.
    Zannad F
    J Cardiovasc Pharmacol; 2000; 35(3 Suppl 1):S19-23. PubMed ID: 11347857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular protective effects of ACE inhibitors and calcium antagonists: theoretical basis for a combination therapy in hypertension and other cardiovascular diseases.
    Lüscher TF; Wenzel RR; Moreau P; Takase H
    Cardiovasc Drugs Ther; 1995 Aug; 9 Suppl 3():509-23. PubMed ID: 8562468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders.
    Sorkin EM; Clissold SP
    Drugs; 1987 Apr; 33(4):296-345. PubMed ID: 3297616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicardipine: a hypotensive dihydropyridine-type calcium antagonist with a peculiar cerebrovascular profile.
    Amenta F; Tomassoni D; Traini E; Mignini F; Veglio F
    Clin Exp Hypertens; 2008 Nov; 30(8):808-26. PubMed ID: 19021030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of long-term treatment with antihypertensive drugs on quality of life of elderly patients with hypertension: a double-blind comparative study between a calcium antagonist and a diuretic. NICS-EH Study Group. National Intervention Cooperative Study in Elderly Hypertensives.
    Ogihara T; Kuramoto K
    Hypertens Res; 2000 Jan; 23(1):33-7. PubMed ID: 10737133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular care with the new T-type calcium channel antagonist: possible role of attendant sympathetic nervous system inhibition.
    Bühler FR
    J Hypertens Suppl; 1997 Dec; 15(5):S3-7. PubMed ID: 9481610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicardipine for hypertensive emergencies in children with renal disease.
    Michael J; Groshong T; Tobias JD
    Pediatr Nephrol; 1998 Jan; 12(1):40-2. PubMed ID: 9502566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular and neuronal hypertensive brain damage: protective effect of treatment with nicardipine.
    Amenta F; Strocchi P; Sabbatini M
    J Hypertens Suppl; 1996 Oct; 14(3):S29-35. PubMed ID: 9120663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicardipine. A review of its pharmacology and therapeutic efficacy in older patients.
    Frampton JE; Faulds D
    Drugs Aging; 1993; 3(2):165-87. PubMed ID: 8477149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicardipine for systemic hypertension: effects on blood pressure and target organ function.
    Ram CV
    Am J Cardiol; 1987 Jun; 59(17):25J-30J. PubMed ID: 3300238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of calcium channel antagonists for cardiovascular disease.
    Yedinak KC
    Am Pharm; 1993 Aug; NS33(8):49-64; quiz 64-6. PubMed ID: 8213473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium channel blockers in cardiovascular pharmacotherapy.
    Godfraind T
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):501-15. PubMed ID: 24872348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular effects of nicardipine.
    Pepine CJ; Lambert CR
    Angiology; 1990 Nov; 41(11 Pt 2):978-86. PubMed ID: 2248426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized double-blind comparison of a calcium antagonist and a diuretic in elderly hypertensives. National Intervention Cooperative Study in Elderly Hypertensives Study Group.
    Hypertension; 1999 Nov; 34(5):1129-33. PubMed ID: 10567194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.
    Thomas GN; Chan P; Tomlinson B
    Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.